Cytokinetics (CYTK) Misses Q3 EPS by 13c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $70.15 +1.27%
Revenue Growth %: -75.3%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -75.3%
Financial Fact:
Total revenues: 59.05M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.36), $0.13 worse than the analyst estimate of ($1.23). Revenue for the quarter came in at $463 thousand versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
- Nutrien warns shareholders about below-market mini-tender offer
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
